openPR Logo
Press release

Follicular Lymphoma Treatment Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025

10-30-2017 11:08 AM CET | Health & Medicine

Press release from: Pharmaceutical

Follicular Lymphoma Treatment Market - Global Industry

Lymphoma refers to the cancer of lymphatic system, which affects the cells of the immune system known as lymphocytes resulting into abnormal multiplication and growth of the cells. Lymphocytes are the white blood cells that protects the body from the infection. It is of two types, namely, Non-Hodgkin and Hodgkin lymphoma. Follicular lymphoma is a type of Non-Hodgkin Lymphoma that affects the lymphocytes. It is the most common indolent type of Non- Hodgkin lymphoma. Follicular lymphoma has symptoms such as enlargement of the lymph nodes in the neck, groin, and abdomen, shortness of breath, weight loss, night sweats, and fatigue.

Follicular lymphoma can be treated on the basis of the acuteness of associated symptoms and on cancer growth rate. Radiation and chemotherapy are presently the responsive treatment for follicular lymphoma. However, radiation alone can be used for the treatment of follicular lymphoma in most of the cases. In more advanced cases chemotherapy or a monoclonal antibody rituximab, alone or the combination of both are used for the treatment of follicular lymphoma. Moreover, monoclonal antibodies are more predominant over the chemotherapy, as they act directly by targeting on tumor cells and thereby, increases immune cells that destructs tumor, which increases response to the treatment.

Rituximab a monoclonal antibody used as a therapeutic agent is expected to augment the market growth

The major factors contributing to the growth of global follicular lymphoma treatment market are rising adoption of monoclonal antibodies for targeted therapies. According to the National Center for Biotechnology Information (NCBI), in 2016, monoclonal antibodies are considered as the successful therapeutics in the cancer treatment. The use of monoclonal antibodies is expected to overcome the side effects, which are generally exhibited by traditional therapies such as radiation and chemotherapy. Therefore, the monoclonal antibody such as rituximab, an anti-CD20 antibody can act as a potential therapeutic agent for the treatment of follicular lymphoma cancer. Moreover, increase in the number of incidence of relapsed follicular lymphoma is also expected to drive the market growth as the number of relapse for the disease results in the same patient availing the treatment multiple times. However, the factors hindering the growth of follicular lymphoma treatment market are the availability of the drugs and high cost of the treatment.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/907

Follicular Lymphoma Treatment Market Taxonomy

Follicular lymphoma treatment is segmented on the basis of treatment type, end user, and geography

On the basis of treatment type, the global follicular lymphoma treatment market is segmented into

Radiation
Targeted therapy
Chemotherapy
Monoclonal antibody
Stem cell transplant

On the basis of end user, the global follicular lymphoma treatment market is segmented into

Hospitals
Speciality centers
Clinics
Cancer Research Institutes

Rising prevalence of follicular lymphoma cases is expected to fuel the market growth in North America

On the basis of geography, the global follicular lymphoma treatment market comprises North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to hold a dominant position in the global follicular lymphoma treatment market, owing to the rise in the follicular lymphoma cases. According to the American Cancer Society (ACS), in 2017, around 72,240 people including adults and children are expected to get diagnosed with follicular lymphoma. Moreover, a series of studies are initiated in the National Cancer Institute, in U.S., to assess the novel emerging sequencing technologies in cancer, as part of the cancer genome characterization. Furthermore, Asia Pacific is expected to hold a major market share in the global follicular lymphoma treatment market over the forecast period. This is mainly owing to advanced research practices adopted by the government and private research institutes of China to curb the follicular lymphoma cancer.

Click here to know more about this report: https://www.coherentmarketinsights.com/ongoing-insight/follicular-lymphoma-treatment-market-907

The innovative Drug Aliqopa launched by Bayer AG’s is expected to propel the market growth

Some of the key players operating in the global follicular lymphoma treatment market include Roche, Spectrum Pharmaceuticals, Johnson and Johnson, CTI Biopharma, Celgene, AbbVie Inc., Novartis, Amgen, Merck & Co. (MRK), Seattle Genetics, Pharmacyclics/ Bristol-Myers Squibb (BMY), and Bayer AG’S. In 2017, Bayer AG’s has launched an innovative drug, Aliqopa, also known as copanlisib, which is a kinase inhibitor that block certain enzymes responsible in promoting cell growth.

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Follicular Lymphoma Treatment Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025 here

News-ID: 792717 • Views: 170

More Releases from Pharmaceutical

Pharmaceutical Market Report 2018 Companies included CCM Pharmaceuticals, Pharma …
We have recently published this report and it is available for immediate purchase. For inquiry Email us on: jasonsmith@marketreportscompany.com ********* This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc. The report also provides
Equine Healthcare Market Global Industry Insights, Trends, 2026
Equine Healthcare refers to the activities and practices aimed for the maintenance of horses. Equine healthcare offers the veterinary services intended for treating horses to enhance their quality of life, develop quality animal food and increase lifespan. The total equine population is directly proportional to the quality of equine healthcare. Equine healthcare includes a number of activities including diagnosis, therapies and supplements for maintaining internal health of horses. The
Novel Drug Delivery System (NDDS) Market - Global Industry Insights
Novel Drug Delivery System (NDDS) refers to the formulations, systems to transport pharmaceutical compound in the body, and approaches needed to achieve the desired therapeutic effect. The side effects and slow processing of conventional drug therapy are contributing to the emergence of novel drug delivery system’s concept. Novel ideas based on interdisciplinary approaches controlling the pharmacodynamics, immunogenicity, pharmacokinetics, bio-recognition, and efficiency of drugs were generated. This new system helps in
The Global Anti-suicide Drugs Market was valued at US$ 3,318.3 million in 2015 a …
The Global Anti-suicide Drugs Market was valued at US$ 3,318.3 million in 2015 and is projected to expand at a CAGR of 4.2% during the forecast period (2016-2024), as highlighted in a new report published by Coherent Market Insights. Introduction of novel approved drugs, expected to be commercialized post-2020, intended for treatment of suicidal ideation would be a major breakthrough for the global anti-suicide drugs market. Until recently, suicidal ideation has

All 5 Releases